News Focus
News Focus
icon url

manibiotech

07/15/25 10:47 AM

#776066 RE: jesster64 #776064

I agree . They want to sell right after approval in my opinion and that's why there has been no hires for marketing , education , distribution team. And I also think they want who acquires to deal with FDA with their clout. 
icon url

FeMike

07/15/25 10:51 AM

#776070 RE: jesster64 #776064

I am at a loss though why any interested company hasn't provided additional funds to nwbo to continue to operate or if there is a limit of shares allowed on the market before B/O?



Why the hell would an interested company have any interest in supporting NWBO prior to a buyout?

The worse off NWBO is, the better the price the purchasing company can get.

They want NWBO to dilute and crash its valuation as much as possible.
icon url

Investor082

07/15/25 11:18 AM

#776076 RE: jesster64 #776064

“I am at a loss though why any interested company hasn't provided additional funds to nwbo to continue to operate or if there is a limit of shares allowed on the market before B/O?”

— the better question to ask is why has LP been diluting in .20s over the last several months, if a deal post approval was pretty much inked (whether that be a partnership (licensing with upfront cash) or a buyout offer). She would be able to negotiate from a position of strength. As a fund, I would want in on a 5 to 10X return in less than an year. Who wouldn’t? More importantly, she would have initiated a loan rather than diluting $17M+ shares at .22 just a week or two ago, if a big cash windfall was coming in the next few months. Tells you everything you need to know.

If you don’t live in denial, it becomes evident that LP has nothing meaningful up her sleeve. That’s why there is no support from the market because everyone expects LP to continue to dilute endlessly for years to come with share price dropping to all low time lows and continue making new all time lows moving forward. The only thing that won’t stop is excuses and kicking of can. Thats been the consistent pattern for the last 15 years!

Expect a request to raise the authorized share count in the coming months.

By the way, what happened to that $50M financing arrangement. Did they exhaust it in the first half of this year?
icon url

HyGro

07/15/25 11:44 AM

#776083 RE: jesster64 #776064

NWBO has had years to attract BP and NONE have been interested. UK approval, if it ever happens, has little attractiveness after being FDA told them not to bother filing. Merck, who has seen ALL of DCVax-Ls data up close, has passed buying at least four other oncology biotechs. In addition, there hasn't been a BP deal with an OTC biotech drug company in the last decade. Not going to happen.